These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 27372519)
1. MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors. Rothschild SI; Gautschi O; Batliner J; Gugger M; Fey MF; Tschan MP Lung Cancer; 2017 May; 107():73-83. PubMed ID: 27372519 [TBL] [Abstract][Full Text] [Related]
2. Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status. Formisano L; D'Amato V; Servetto A; Brillante S; Raimondo L; Di Mauro C; Marciano R; Orsini RC; Cosconati S; Randazzo A; Parsons SJ; Montuori N; Veneziani BM; De Placido S; Rosa R; Bianco R Oncotarget; 2015 Sep; 6(28):26090-103. PubMed ID: 26325669 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma. Rothschild SI; Tschan MP; Federzoni EA; Jaggi R; Fey MF; Gugger M; Gautschi O Oncogene; 2012 Sep; 31(38):4221-32. PubMed ID: 22249264 [TBL] [Abstract][Full Text] [Related]
4. Negative Regulation of ULK1 by microRNA-106a in Autophagy Induced by a Triple Drug Combination in Colorectal Cancer Cells Salgado-García R; Coronel-Hernández J; Delgado-Waldo I; Cantú de León D; García-Castillo V; López-Urrutia E; Gutiérrez-Ruiz MC; Pérez-Plasencia C; Jacobo-Herrera N Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33572255 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-106a Inhibits Autophagy Process and Antimicrobial Responses by Targeting ULK1, ATG7, and ATG16L1 During Mycobacterial Infection. Liu K; Hong D; Zhang F; Li X; He M; Han X; Zhang G; Xu G; Stonehouse NJ; Jiang Z; An W; Guo L Front Immunol; 2020; 11():610021. PubMed ID: 33505399 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of ULK1 by microRNA-372 inhibits the survival of human pancreatic adenocarcinoma cells. Chen H; Zhang Z; Lu Y; Song K; Liu X; Xia F; Sun W Cancer Sci; 2017 Sep; 108(9):1811-1819. PubMed ID: 28677209 [TBL] [Abstract][Full Text] [Related]
7. SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways. Tang F; Hu P; Yang Z; Xue C; Gong J; Sun S; Shi L; Zhang S; Li Z; Yang C; Zhang J; Xie C Oncol Rep; 2017 Jun; 37(6):3449-3458. PubMed ID: 28498429 [TBL] [Abstract][Full Text] [Related]
8. miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124. Gao Y; Fan X; Li W; Ping W; Deng Y; Fu X Biochem Biophys Res Commun; 2014 Mar; 446(1):179-86. PubMed ID: 24582749 [TBL] [Abstract][Full Text] [Related]
9. LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients. Kim YJ; Hong S; Sung M; Park MJ; Jung K; Noh KW; Oh DY; Lee MS; Oh E; Shin YK; Choi YL Oncotarget; 2016 Dec; 7(50):82876-82888. PubMed ID: 27756880 [TBL] [Abstract][Full Text] [Related]
10. Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma. Chua KN; Kong LR; Sim WJ; Ng HC; Ong WR; Thiery JP; Huynh H; Goh BC Oncotarget; 2015 Oct; 6(30):29991-30005. PubMed ID: 26358373 [TBL] [Abstract][Full Text] [Related]
11. Curcumin increases crizotinib sensitivity through the inactivation of autophagy via epigenetic modulation of the miR-142-5p/Ulk1 axis in non-small cell lung cancer. He YZ; Yu SL; Li XN; Bai XH; Li HT; Liu YC; Lv BL; Zhao XM; Wei D; Zhang HL; Li FN; Li G; Li S Cancer Biomark; 2022; 34(2):297-307. PubMed ID: 34957997 [TBL] [Abstract][Full Text] [Related]
12. Silencing of NRAGE induces autophagy via AMPK/Ulk1/Atg13 signaling pathway in NSCLC cells. Zhou Y; Huang N; Wu J; Zhen N; Li N; Li Y; Li YX Tumour Biol; 2017 Jun; 39(6):1010428317709676. PubMed ID: 28639909 [TBL] [Abstract][Full Text] [Related]
13. Investigation the Role of Autophagy in Non-Small Cell Lung Cancer. Pargol M; Zare Karizi S; Akbari M; Nourmohammadi B; Shadmehr MB; Karimipoor M; Zare Karizi S Asian Pac J Cancer Prev; 2021 Mar; 22(3):947-955. PubMed ID: 33773561 [TBL] [Abstract][Full Text] [Related]
14. Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics. Zhang X; Belkina N; Jacob HK; Maity T; Biswas R; Venugopalan A; Shaw PG; Kim MS; Chaerkady R; Pandey A; Guha U Proteomics; 2015 Jan; 15(2-3):340-55. PubMed ID: 25404012 [TBL] [Abstract][Full Text] [Related]
15. Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer. Phan AN; Hua TN; Kim MK; Vo VT; Choi JW; Kim HW; Rho JK; Kim KW; Jeong Y Oncotarget; 2016 Aug; 7(34):54702-54713. PubMed ID: 27419630 [TBL] [Abstract][Full Text] [Related]
16. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells. Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317 [TBL] [Abstract][Full Text] [Related]
17. Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways. Lai YH; Chen MH; Lin SY; Lin SY; Wong YH; Yu SL; Chen HW; Yang CH; Chang GC; Chen JJ Oncotarget; 2015 Sep; 6(28):26252-65. PubMed ID: 26312766 [TBL] [Abstract][Full Text] [Related]
18. Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin. Ceppi P; Papotti M; Monica V; Lo Iacono M; Saviozzi S; Pautasso M; Novello S; Mussino S; Bracco E; Volante M; Scagliotti GV Mol Cancer Ther; 2009 Nov; 8(11):3066-74. PubMed ID: 19861409 [TBL] [Abstract][Full Text] [Related]
19. Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling. Ye M; Zhang Y; Gao H; Xu Y; Jing P; Wu J; Zhang X; Xiong J; Dong C; Yao L; Zhang J; Zhang J Clin Cancer Res; 2018 Mar; 24(5):1227-1239. PubMed ID: 29229632 [No Abstract] [Full Text] [Related]
20. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy. Hua L; Zhu G; Wei J Cell Biol Int; 2018 Sep; 42(9):1240-1249. PubMed ID: 29851226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]